The IMF's Patience with the ECB Wears Thin
The updated World Economic Outlook reveals that the IMF is (rightly) fed up with the ECBās timid approach to monetary policy.Ā Ā Monetary policy in...
507 Views
Never Trust A Swiss Central Banker
Post SNB surprise announcement yesterday - after leading the market on as recently as a few weeks ago on ā the term āNever trust a Swiss central...
517 Views
RemegenĀ (9995 HK): New Licensing Deal With AbbVie Brings $650M Upfront Cash
Remegen inked an exclusive outlicensing deal with AbbVie for RC148, an investigational PD-1/ VEGF bispecific antibody drug candidate for an upfront...
272 Views
Primer: AbbVie (ABBV UN) - Sep 2025
AbbVie is successfully navigating the loss of exclusivity for its former blockbuster drug, Humira, driven by the robust growth of its...
84 Views
Simcere Pharmaceutical (2096 HK) Placement: Innovative Pipeline Enlightens Growth Prospects
Simcere Pharmaceutical is placing 120M shares at the price of HK$12.95 per share. The company intends to apply 90% of the net proceeds for the R&D...
402 Views